Jolanta Lorentzen

Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial

Marius Svanevik, Jolanta Lorentzen, Heidi Borgeraas et al. · The Lancet Diabetes & Endocrinology · 2023 · 48 citations · Full text

Obesity, Bariatric Surgery, Diabetes Management +9

Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial

Jostein Wågen Hauge, Heidi Borgeraas, Kåre I. Birkeland et al. · The Lancet Diabetes & Endocrinology · 2025 · 19 citations

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity <i>s</i> urg <i>e</i> ry in Tøns <i>berg</i> ( <i>O</i> seberg) study

Heidi Borgeraas, Jøran Hjelmesæth, Kåre I. Birkeland et al. · BMJ Open · 2019 · 16 citations · Full text

Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional Study

Jolanta Lorentzen, Asle W. Medhus, Jens Kristoffer Hertel et al. · Obesity Surgery · 2020 · 13 citations · Full text

Obesity, Metabolic Syndrome, Esophageal Cancer +7